Rural Illinois Lung Cancer Screening Initiative
ConditionLung Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50-80
SponsorSouthern Illinois University
About this trial
The role of this observational study is to access the feasibility of providing lung cancer screening using a designated nurse navigator through lung cancer screening clinic. Eligible participants will be identified using medical records, eligibility will be confirmed through phone call, screening visits will be scheduled as in-person visit or telehealth visit. Computed tomography screening will be performed at an approved center closer to the individuals place of living and results will be discussed during follow-up in-person visit or telehealth visit.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All individuals 50-80 years of age
20 pack-year smoking history
Disqualifiers
Individuals 49 years and below or 81 years and above
Has not smoked in 15 or more years
Individuals who develop a health problem that makes them unwilling or unable to have surgery if lung cancer is detected.
Trial population
The risk of lung cancer increases with age and smoking status and hence this age range is recommended for receiving lung cancer screening. As per USPSTF criteria our screening initiative will include individuals 50-80 years, subjects of all sex/gender and all race/ethnic groups. Screening eligible individuals included in our pilot study consisted of 54.4 % women, 75% of non-Hispanic whites, 24% non-Hispanic blacks and 1.2% belonged to 'other' race category. Non-Hispanic black individuals with smoking history have a higher risk of developing lung cancer than a non-Hispanic white. Very few Hispanic persons and women tend to accumulate fewer pack-years over a long period of time.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
10,000 Participants
are grouped into 2 trial groupsGroup A: Telehealth cohort
Group B: In-person cohort
Trial outcomes
Primary outcomes
1
Screening rate
Percentage of individuals screened (completed CT imaging) with and without telehealth
Time frame
Through study completion, an average of 1 year2
Early stage diagnosis
Percentage of individuals diagnosed with lung cancer at an early stage of the disease
Time frame
Through study completion, an average of 1 yearSecondary outcomes
1
Time to treatment initiation
Number of days from diagnosis to treatment initiation will be calculated for each patient diagnosed with lung cancer
Time frame
Through study completion, an average of 1 year2
Adherence to Screening
Percentage of of individuals undergoing yearly screening with and without telehealth
Time frame
Through study completion, an average of 1 year3
Cost
Overall cost from pre-screening to screening and follow-up with and without telehealth
Time frame
Through study completion, an average of 1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov